New PET agent sees early tumors
Researchers from Vanderbilt University have developed PET imaging agents that could make it possible to visualize tumors in their earliest stages before they become deadly, according to a study in the October issue of Cancer Prevention Research.
The compounds, derived from inhibitors of the enzyme cyclooxygenase-2 (COX-2) and detectable by PET, may have broad applications for cancer detection, diagnosis, and treatment.
New Data Shows Decline in Medical Imaging Utilization
A new analysis of Medicare data finds that spending on medical imaging continues to decline and that Medicare patients are receiving fewer imaging procedures. Learn More
MITA Now Includes Radiopharmaceutical Industry in Membership
With new membership MITA unites both halves of nuclear medicine. Learn More
CT Lung Cancer Screening Named Top Five Advance in 2011
The American Society of Clinical Oncology (ASCO) named CT-based lung cancer screening amongst 2011’s top five advances in its annual report on progress against cancer. Learn More
- © 2012 National Electrical Manufacturers Association |
- Privacy Policy |
- Terms & Conditions